Product Information for the User
Lysodren 500 mg Tablets
mitotane
Read this entire product information carefully before starting to take this medicine, as it contains important information for you.
Always carry the Lysodren Patient Card that is attached at the end of this product information with you.
Lysodren is a medication for cancer treatment that contains the active ingredient mitotane.
This medication is used for the symptomatic treatment of advanced, inoperable, recurrent, or metastatic malignant tumors of the adrenal glands.
Do not take Lysodren
Warnings and precautions
Consult your doctor or pharmacist before starting to take Lysodren.
You must inform your doctor if you are in any of the following cases:
You must not handle this medication except by the patient and the people who take care of them, and especially not by pregnant women. People who take care of the patient should use disposable gloves when handling the tablets.
During treatment with Lysodren
Lysodren may temporarily decrease the amount of hormones produced by your adrenal gland (cortisol), but your doctor will correct this using the appropriate hormone medication (steroids).
Lysodren may cause bleeding that lasts longer than usual. If you need to undergo surgery or dental procedures during treatment with Lysodren, your healthcare professional will perform blood tests to check the risk of prolonged bleeding.
Always carry the Lysodren Patient Card that is attached to the end of this leaflet with you.
Other medications and Lysodren
Inform your doctor or pharmacist if you are using or have recently used other medications, even those purchased without a prescription.
You must not take Lysodren with medications that contain spironolactone, a medication that is often used as a diuretic to treat heart, liver, or kidney diseases.
Lysodren may also interfere with other medications. Therefore, if you take any medication that contains any of the following active substances, you must tell your doctor:
Taking Lysodren with food and drinks
Lysodren should be taken preferably during meals, with fatty foods such as milk, chocolate, or oil.
Pregnancy, breastfeeding, and fertility
Lysodren may harm the fetus. If you are pregnant, think you may be pregnant, or intend to become pregnant, inform your doctor as soon as possible to know if you should interrupt or continue treatment with Lysodren.
Women of childbearing age should use an effective contraceptive method during treatment with Lysodren, even after treatment has been interrupted. You must consult your doctor.
Due to the potential for severe adverse reactions in your baby, do not breastfeed your child if you take Lysodren, even after treatment has been interrupted. Consult your doctor.
Driving and operating machinery
The influence of Lysodren on your ability to drive and operate machinery is important. Consult your doctor.
Dosage and Administration
The usual starting dose is 2 to 3 g (4 to 6 tablets) per day.
Your doctor may start treatment with higher doses such as 4 to 6 g (8 to 12 tablets).
To select the optimal dose to treat your condition, your doctor will regularly monitor the amount of Lysodren in your blood. Your doctor may decide to temporarily stop or reduce the Lysodren treatment if you experience certain adverse effects.
Use in Children and Adolescents
The starting daily dose of Lysodren is 1.5 to 3.5 g/m2of body surface area (your doctor will calculate this based on the child's weight and size). Experience in patients of this age group is very limited.
Administration Form
You should take the tablets with a glass of water during meals that contain high-fat foods. The total daily dose can be administered in two or three doses.
If You Take More Lysodren Than You Should
Contact your doctor immediately if you accidentally take more Lysodren than you should or if a child accidentally ingests a tablet.
If You Forget to Take Lysodren
If you accidentally forget to take a dose, take the next dose according to the established dosage. Do not take a double dose to compensate for the missed dose.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Inform your doctor immediatelyif you experience any of the following side effects:
These symptoms may indicate complications, for which it may be appropriate to use a specific medication.
These side effects may occur with certain frequencies that are defined below:
Very frequent side effects
Frequent side effects
Unknown frequency
In children and adolescents, thyroid problems, neuropsychological problems, growth retardation, and a case of encephalopathy have been observed. Additionally, some signs of hormonal changes (such as excessive breast development in men and vaginal bleeding and/or early breast development in women) have been observed.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through thenational notification system included in theAppendix V.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Store in the original packaging. Once opened: 1 year.
Do not use this medication after the expiration date that appears on the box and on the bottle after CAD.
The disposal of unused medication and all materials that have come into contact with it, will be carried out in accordance with local regulations for cytotoxic medications.
Medications should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of medications that you no longer need. This will help protect the environment.
Lysodren Composition
macrogol 3350 and anhydrous colloidal silica.
Appearance of the product and contents of the package
Lysodren tablets are white, biconvex, round, and scored.
Lysodren is presented in plastic bottles of 100 tablets
Marketing Authorization Holder:
Esteve RD France SAS
25 Boulevard Romain Rolland
92120 Montrouge
France
Responsible for manufacturing:
Latina Pharma S.p.A.
Via Murillo, 7
04013 Sermoneta (LT)
Italy
or
Centre Specialites Pharmaceutiques
76-78, avenue du Midi
63800 Cournon d’Auvergne
France
Last review date of this leaflet: 11.2024
Other sources of information
The detailed information on this medicine is available on the website of the European Medicines Agency: http://www.ema.europa.eu. There are also links to other websites on rare diseases and orphan medicines.
On the website of the European Medicines Agency, this leaflet can be found in all languages of the European Union/European Economic Area.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
LYSODREN: PATIENT CARD
I amunder treatment with Lysodren (mitotane) I have a tendency to acute adrenal insufficiency if I need urgent medical attention, appropriate precautions should be taken | My doctor's name is: ……………………………………….. Phone: ………………………………. For more information about the product,,please contact: Esteve RD France SAS Phone: + 33 1 40 33 93 14 |
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.